Repeated measurements of the biomarker FIB-4 in the blood every few years can predict the risk of developing severe liver disease, according to a new study from Karolinska Institutet in Sweden published in the Journal of Hepatology. The risk of liver cirrhosis increases if the levels of this biom…
This is the ideal opportunity for you to learn from some of the biggest names in hepatology and meet them in an engaging & interactive setting! See below the list with the “Meet the experts” sessions from the Digital ILC 2020. Non-invasive assessment in NAFLD…
Scientists have identified a microRNA in obese mouse mothers that may increase the odds of liver cancer in their offspring throughout multiple generations, report scientists in the Journal of Hepatology. Amsterdam, June 25, 2020 – Scientists recognise the connection between maternal obesity and l…
EASL has been actively working to beat liver disease, including NAFLD & NASH, through its schools and key event, the NAFLD Summit. EASL has also developed a Policy Statement on the measures required to prevent and treat this common progressive condition. Globally, 1 in 4 people are living with fa…
Women with non-alcoholic fatty liver disease (NAFLD) should receive preconception counselling on increased maternal and infant risks, while pregnant mothers may benefit from evaluation by a high-risk obstetrics team, recommend scientists in the Journal of Hepatology. Oxford, June 9, 2020 – Non-al…
Be a part of this innovative and engaging digital event for the liver community to connect and learn via cutting-edge content. Enjoy three days of immersive and lively exchanges at the Digital International Liver Congress™ 2020 from 27 to 29 August 2020. Enjoy the benefit of early fees and regist…
The EASL members’ General Assembly, usually held within the framework of the International Liver Congress™, will take place as an online meeting on Monday, 29 June 2020 at 17:00–19:00 CET. The General Assembly is a key opportunity for EASL members and the Governing Board to come together, to disc…
A new international study has found increased mortality rates from COVID-19 among people with chronic liver disease and cirrhosis and has called for patients with worsening liver function to be tested for coronavirus. The researchers, led by teams at Oxford University Hospitals NHS Foundation Tru…
In a webinar jointly run by EASL and the World Health Organization (WHO), virology and hepatology experts compared strategies in coping during the current pandemic. They described a rise in innovative, cooperative mitigating approaches, but noted that essential hepatitis and other liver-related s…
Given the continuing impact of the SARS-CoV-2 pandemic and resulting restrictions, EASL has decided to transition the onsite International Liver Congress™ 2020, planned for 25–28 August, to an immersive and exciting digital event – The Digital International Liver Congress™ 2020, which will be hel…
